Ingrid M Frohn-Mulder
Overview
Explore the profile of Ingrid M Frohn-Mulder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gnanam D, Bartelds B, van Leeuwen W, Frohn-Mulder I, Koopman L
Echocardiography
. 2019 Jun;
36(7):1427-1430.
PMID: 31237036
Coarctation of aorta(CoA), complicated by endarteritis in a children is very rare. Here we present a case of endarteritis in an unoperated CoA in a four year old boy. CoA...
2.
van Capelle C, Poelman E, Frohn-Mulder I, Koopman L, van den Hout J, Regal L, et al.
Int J Cardiol
. 2018 Jul;
269:104-110.
PMID: 30049495
Background: Cardiac failure is the main cause of death in untreated classic infantile Pompe disease, an inheritable metabolic myopathy characterized by progressive hypertrophic cardiomyopathy. Since the introduction of enzyme replacement...
3.
Kerstjens-Frederikse W, van de Laar I, Vos Y, Verhagen J, Berger R, Lichtenbelt K, et al.
Genet Med
. 2016 Jan;
18(9):914-23.
PMID: 26820064
Purpose: We aimed to determine the prevalence and phenotypic spectrum of NOTCH1 mutations in left-sided congenital heart disease (LS-CHD). LS-CHD includes aortic valve stenosis, a bicuspid aortic valve, coarctation of...
4.
Wessels M, Herkert J, Frohn-Mulder I, Dalinghaus M, van den Wijngaard A, de Krijger R, et al.
Eur J Hum Genet
. 2014 Oct;
23(7):922-8.
PMID: 25335496
Familial hypertrophic cardiomyopathy (HCM) is usually caused by autosomal dominant pathogenic mutations in genes encoding sarcomeric or sarcomere-associated cardiac muscle proteins. The disease mainly affects adults, although young children with...
5.
Brands M, Frohn-Mulder I, Hagemans M, Hop W, Oussoren E, Helbing W, et al.
J Inherit Metab Dis
. 2012 Jan;
36(2):227-34.
PMID: 22278137
We determined the cardiologic features of children with MPS I, II and VI, and evaluated the effect of enzyme-replacement therapy (ERT) on cardiac disease. Twenty-four children aged 1-18 years with...